Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile | Zendy

Monica Zolezzi | Zendy; Rawan Abouelhassan | Zendy; Yassin Eltorki | Zendy; Peter Haddad | Zendy; Mahtab Noorizadeh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Author(s) -

Monica Zolezzi,

Rawan Abouelhassan,

Yassin Eltorki,

Peter Haddad,

Mahtab Noorizadeh

Publication year - 2021

Publication title -

neuropsychiatric disease and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 67

eISSN - 1178-2021

pISSN - 1176-6328

DOI - 10.2147/ndt.s309768

Subject(s) - medicine , adverse effect , injection site , clinical trial , incidence (geometry) , optics , physics

Long acting injectable (LAI) antipsychotics are commonly used in the treatment of schizophrenia to improve adherence and clinical outcomes. Concerns have been reported in relation to their non-systemic or injection site adverse effect profile. As such, this study aims to review and evaluate all evidence reporting injection site adverse effects with LAI antipsychotics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research